ArticleJournal of clinical medicine2023

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats.

Habib Yaribeygi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.